🇺🇸 FDA
Pipeline program

Cannabidiol

GWEP19022

Approved small_molecule active

Quick answer

Cannabidiol for Lennox Gastaut Syndrome is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Lennox Gastaut Syndrome
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials